Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
December 2013 National MS eNEWS
Breakthrough cognitive study will change lives

Researchers use memory training to restore loss

Kessler Foundation researchers report results of a clinical trial showing that a specific type of memory training improves learning in people with MS for at least six months after the training has ended—and benefits other aspects of quality of life as well. These results could help improve insurance coverage of cognitive therapy moving forward. Get the study details

Related: How exercise impacts memory is the focus of one of three new studies looking into lifestyle choices and MS.

Cognition challenges and the holidays

Connect to discuss cognition with others


Katie Jennings

A new option for progressive MS?


MS, Connections and Empowered Living

MS, Connections and Empowered Living


facebook twitter youtube flickr linkedin


Affordable Care Act 2013 advances in MS research

The Society invested $48 million this year to drive 380 new and ongoing MS studies, including a clinical trial in ibudilast for progressive MS. Lives moved forward with the FDA approval of a third oral MS therapy, results of studies testing novel cell-based repair strategies, and much more.

Learn more


MS ScholarshipsLooking for the right holiday gift?

This year, give your loved one something they’ll never forget. Special holiday offer ends December 25.

Give now


More MS News

Dec 16: Medicare Advantage plan members may switch to original Medicare during the annual disenrollment period Jan 1 to Feb 14

Dec 4: Vaccine used to prevent tuberculosis may open new treatment approach to preventing or treating MS

Dec 2: Trainees in MS research and clinical care connect at the 2013 Tykeson Fellows Conference

Read more about these and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Genzyme, a Sanofi company; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS Active Source Genzyme, a Sanofi company Novartis Pharmaceuticals
Teva Neuroscience, Inc.
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to  .
To ensure that you continue to receive our emails, please add us to your address book.